R&D Systems™ Recombinant Human TSHR Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 8950TR050
DescriptionThe Recombinant Human TSH R Fc Chimera Protein is derived from CHO. The Recombinant Human TSH R Fc Chimera Protein has been validated for the following applications: Bioactivity.
|Chinese Hamster Ovary cell line, CHO-derived Human TSH R (Met22-Gly413) Accession # P16473, N-terminus; IEGRMD; Human IgG1 (Pro100-Lys330), C-terminus|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|CHNG1, LGR3, LGR3hTSHR-I, MGC75129, seven transmembrane helix receptor, thyroid stimulating hormone receptor, Thyroid-stimulating hormone receptor, thyrotropin receptor, thyrotropin receptor-I, hTSHR-I, TSH R, TSH-R|
|Theoretical M.W.: 71kDa|
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|Chinese Hamster Ovary cell line,CHO-derived human TSH R protein, (N-terminus) Human TSH R (Met22-Gly413) Accession &Num; P16473 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Measured by its ability to inhibit rhTSH-induced cAMP accumulation in HEK293 human embryonic kidney cells transfected with human TSH R. The ED50 for this effect is typically 2-12μg/mL.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok